Nanocomplex hyaluronic acid/ganciclovir@ZIF-8 for ganciclovir efficient delivery and targeted anti-KSHV treatment

Nanocomplex hyaluronic acid/ganciclovir@ZIF-8 for ganciclovir efficient delivery and targeted anti-KSHV treatment

Abstract Kaposi's sarcoma-associated herpesvirus (KSHV) infection can cause a variety of tumors and is one of the leading causes of death in acquired immune deficiency syndrome (AIDS) patients. As a small molecule antiviral drug, ganciclovir (GCV) can be used for anti-KSHV treatment. However, G...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fangling Li, Chengjing Liu, Wenyi Gu, Qianhe Xu, Dongmei Li, Dongdong Cao, Zhiyong Liu
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	Cancer Nanotechnology
Subjects:	Anti-KSHV treatment Ganciclovir Drug-carrying nanocomplex pH-responsive drug release
Online Access:	https://doi.org/10.1186/s12645-024-00303-0
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dual Resistance to Maribavir and Ganciclovir in Transplant Recipients
by: Steven B. Kleiboeker
Published: (2025-03-01)

In-situ gel bases ocular delivery system of Ganciclovir, in-vivo and in-vitro investigation
by: Susanta Paul, et al.
Published: (2025-05-01)

Efficacy and toxicity analysis of ganciclovir in patients with cytomegalovirus lung infection: what is new for target range of therapeutic drug monitoring
by: Dongjie Guo, et al.
Published: (2025-08-01)

Foscarnet Versus Ganciclovir for Severe Congenital Cytomegalovirus Infection: Short- and Long-Term Follow-Up
by: Giovanni Nigro, et al.
Published: (2025-05-01)

Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-MS/MS Method
by: T. N. Komarov, et al.
Published: (2021-02-01)

Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-UV Method
by: T. N. Komarov, et al.
Published: (2020-05-01)

Cytopathic effects and local immune responses in repeated neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer
by: Nobuyuki Yanagisawa, et al.
Published: (2021-07-01)

PE-028 Análise de Custo-Minimização entre Ganciclovir e Valganciclovir para o Tratamento da Retinite por Citomegalovírus em Pessoas Vivendo com o Vírus da Imunodeficiência Humana
by: Álex Brunno do Nascimento Martins, et al.
Published: (2025-03-01)

Real-world efficacy and safety of letermovir versus ganciclovir prophylaxis in adolescent patients undergoing allogenic hematopoietic stem cell transplantation: a single center observational study
by: Ziwei Xu, et al.
Published: (2025-06-01)

Rewriting Viral Fate: Epigenetic and Transcriptional Dynamics in KSHV Infection
by: Chunyan Han, et al.
Published: (2024-11-01)

Glatiramer–diclofenac nanocomplex enhances remyelination in a mouse model of multiple sclerosis
by: Bander M. Aldhabi, et al.
Published: (2025-05-01)

Comparison of the indirect immunofluorescence assay and a commercial ELISA to detect KSHV antibodies
by: Valentin Leducq, et al.
Published: (2024-11-01)

The Role of vIL-6 in KSHV-Mediated Immune Evasion and Tumorigenesis
by: Somayeh Komaki, et al.
Published: (2024-12-01)

A KSHV-targeted small molecule efficiently blocks SARS-CoV-2 infection via inhibiting expression of EGFR and Cyclin A2
by: Zhongwei Dong, et al.
Published: (2025-12-01)

Protective Effects of Zein/Ferulic Acid (FA)–Pectin (PEC)/Chitosan (CS) Nanocomplexes on DSS-Induced Ulcerative Colitis in Mice
by: Yifei Guo, et al.
Published: (2025-07-01)

Cytomegalovirus hepatitis and ganciclovir treatment in immunocompetent children
by: Hasan Tezer, et al.
Published: (2008-06-01)

Unveiling Theranostics: Nanocomplex-Assisted Photodynamic Eradication of Aggressive Cancer Cells and Modulation of Tumor-Associated Macrophages
by: Butkute A, et al.
Published: (2025-08-01)

Neighboring Effect‐Initiated Supramolecular Nanocomplex with Sequential Infiltration as Irreversible Apoptosis Inducer for Synergetic Chemo‐Immunotherapy
by: Mengjie Ye, et al.
Published: (2024-10-01)

Treatment of CMV Retinitis with Intravitreal Ganciclovir in the HAART Era
by: Robert J Campbell, et al.
Published: (2001-01-01)

Virus-Mimicking Polymer Nanocomplexes Co-Assembling HCV E1E2 and Core Proteins with TLR 7/8 Agonist—Synthesis, Characterization, and In Vivo Activity
by: Thomas R. Fuerst, et al.
Published: (2025-01-01)

IFI16 Mediates Deacetylation of KSHV Chromatin via Interaction with NuRD and Sin3A Co-Repressor Complexes
by: Anandita Ghosh, et al.
Published: (2025-06-01)

Characteristics of physical and chemical properties, antioxidant, antimutagenic and reparative activity of nanocomplexes of curcuminoids with cyclodextrins
by: M. A. Kapustin, et al.
Published: (2024-05-01)

Synergistic effects of Fe nanocomplex and nitrophenolate-based biostimulant on growth and physiological performance of tomato seedlings
by: Vahid Tavallali, et al.
Published: (2025-07-01)

In Silico Analysis of Mechanisms of Maribavir-Induced Inhibition and Drug Resistance Mutations in pUL97 Kinase Structural Prediction with AlphaFold2
by: Jocelyne Piret, et al.
Published: (2025-07-01)

Progress and Challenges in the Management of Congenital Cytomegalovirus Infection
by: Weronika Szulc, et al.
Published: (2024-11-01)

Infant feeding and treatment practices could lead to enhanced transmission of Kaposi’s sarcoma-associated herpesvirus (KSHV) and other orally shed infections via saliva, in rural south-western Uganda
by: Dominic Bukenya, et al.
Published: (2024-12-01)

Selective suppression of influenza A/H5N1 virus replication <i>in vitro</i> using nanocomplexes consisting of siRNA and aminopropylsilanol nanoparticles
by: Marina N. Repkova, et al.
Published: (2024-12-01)

Encapsulation of a drug into electrospun fibers spun from water soluble polymers to control solubility and release
by: Lan Yi, et al.
Published: (2024-10-01)

Ganciclovir Antiviral Therapy in Advanced Idiopathic Pulmonary Fibrosis: An Open Pilot Study
by: J. J. Egan, et al.
Published: (2011-01-01)

Optimal Use of Ganciclovir and Valganciclovir in Transplanted Patients: How Does It Relate to the Outcome?
by: Maryam Mozaffar, et al.
Published: (2018-01-01)

Long Term Therapy of Cytomegalovirus Retinitis with Ganciclovir in a Child with Acquired Immunodeficiency Syndrome
by: Scott A Halperin, et al.
Published: (1993-01-01)

Cytomegalovirus Retinitis in an ALL Child during Maintenance Therapy Treated Successfully with Intravenous Ganciclovir
by: Hande Celiker, et al.
Published: (2014-01-01)

Uso de ganciclovir na abordagem terapêutica da ceratite ulcerativa herpética felina
by: Tarcísio Guerra Guimarães, et al.
Published: (2024-11-01)

Epigenetic and epitranscriptomic regulation during oncogenic γ-herpesvirus infection
by: Rajnish Kumar Singh, et al.
Published: (2025-01-01)

Tackling CMV in Transplant Recipients: Past, Present, and Future
by: Tal Schlaeffer-Yosef, et al.
Published: (2025-04-01)

Anthocyanin-loaded complexes of glycated dual milk-derived proteins: thermal stability, storage stability, and simulated digestion
by: Shuangshuang Wang, et al.
Published: (2025-09-01)

Drug Incompatibilities and Complex Assemblies: Let Us Remain Vigilant!
by: Cordélia Salomez-Ihl, et al.
Published: (2025-04-01)

KSHV reprograms host RNA splicing via FAM50A to activate STAT3 and drive oncogenic cellular transformation
by: Shenyu Sun, et al.
Published: (2025-07-01)

The Role of Ganciclovir for the Management of Cytomegalovirus Retinitis in HIV Patients: Pharmacological Review and Update on New Developments
by: Alice Tseng, et al.
Published: (1996-01-01)

Ganciclovir-Resistant Cytomegalovirus Infection in a Kidney Transplant Recipient Successfully Treated with Foscarnet and Everolimus
by: Viola Menghi, et al.
Published: (2016-01-01)